Symbols / INAB Stock $1.57 +8.28% IN8bio, Inc.

Healthcare • Biotechnology • United States • NCM
INAB (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country NCM · United States
Market Cap 15.46M
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand —
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close $1.45
Price $1.57
Change 8.28%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest INAB news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
19.86
-32.90%
29.60
-1.36%
30.01
+5.21%
28.52
Research And Development
10.21
-39.80%
16.96
+0.80%
16.83
+19.66%
14.06
Selling General And Administration
9.65
-23.64%
12.64
-6.46%
13.51
-6.56%
14.46
General And Administrative Expense
9.65
-23.64%
12.64
-6.46%
13.51
-6.56%
14.46
Other Gand A
9.65
-23.64%
12.64
-6.46%
13.51
-6.56%
14.46
Other Operating Expenses
—
—
-0.33
—
Total Expenses
19.86
-32.90%
29.60
-1.36%
30.01
+5.21%
28.52
Operating Income
-19.86
+32.90%
-29.60
+1.36%
-30.01
-5.21%
-28.52
Total Operating Income As Reported
-19.44
+36.13%
-30.44
-1.43%
-30.01
-5.21%
-28.52
EBITDA
-17.36
+35.57%
-26.94
+2.04%
-27.51
-0.32%
-27.42
Normalized EBITDA
-17.36
+32.91%
-25.88
+5.93%
-27.51
-0.32%
-27.42
Reconciled Depreciation
2.50
-5.80%
2.65
+6.16%
2.50
+126.75%
1.10
EBIT
-19.86
+32.90%
-29.60
+1.36%
-30.01
-5.21%
-28.52
Total Unusual Items
0.00
+100.00%
-1.07
0.00
—
Total Unusual Items Excluding Goodwill
0.00
+100.00%
-1.07
0.00
—
Special Income Charges
0.00
+100.00%
-1.07
0.00
—
Restructuring And Mergern Acquisition
0.00
-100.00%
1.07
0.00
—
Net Income
-19.44
+36.13%
-30.44
-1.43%
-30.01
-5.21%
-28.52
Pretax Income
-19.44
+36.13%
-30.44
-1.43%
-30.01
-5.21%
-28.52
Net Non Operating Interest Income Expense
0.42
+83.04%
0.23
0.00
—
Net Interest Income
0.42
+83.04%
0.23
0.00
—
Interest Income Non Operating
0.42
+83.04%
0.23
0.00
—
Interest Income
0.42
+83.04%
0.23
0.00
—
Other Income Expense
—
-1.07
-423.64%
0.33
—
Other Non Operating Income Expenses
—
—
0.33
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-19.44
+36.13%
-30.44
-1.43%
-30.01
-5.21%
-28.52
Net Income From Continuing Operation Net Minority Interest
-19.44
+36.13%
-30.44
-1.43%
-30.01
-5.21%
-28.52
Net Income From Continuing And Discontinued Operation
-19.44
+36.13%
-30.44
-1.43%
-30.01
-5.21%
-28.52
Net Income Continuous Operations
-19.44
+36.13%
-30.44
-1.43%
-30.01
-5.21%
-28.52
Normalized Income
-19.44
+33.81%
-29.37
+2.13%
-30.01
-5.21%
-28.52
Net Income Common Stockholders
-19.44
+36.13%
-30.44
-1.43%
-30.01
-5.21%
-28.52
Diluted EPS
-4.44
+73.96%
-17.05
+43.17%
-30.00
+26.47%
-40.80
Basic EPS
-4.44
+73.96%
-17.05
+43.17%
-30.00
+26.47%
-40.80
Basic Average Shares
4.37
+145.08%
1.78
+79.30%
1.00
+42.43%
0.70
Diluted Average Shares
4.37
+145.08%
1.78
+79.30%
1.00
+42.43%
0.70
Diluted NI Availto Com Stockholders
-19.44
+36.13%
-30.44
-1.43%
-30.01
-5.21%
-28.52
Line Item Trend 2023-12-31
Total Assets
33.71
Current Assets
24.62
Cash Cash Equivalents And Short Term Investments
21.28
Cash And Cash Equivalents
21.28
Cash Financial
21.28
Prepaid Assets
3.07
Other Current Assets
0.27
Total Non Current Assets
9.08
Net PPE
8.57
Gross PPE
9.86
Accumulated Depreciation
-1.28
Properties
0.00
Machinery Furniture Equipment
0.88
Construction In Progress
0.18
Other Properties
4.88
Leases
3.92
Goodwill And Other Intangible Assets
—
Other Intangible Assets
—
Non Current Deferred Assets
—
Other Non Current Assets
0.51
Total Liabilities Net Minority Interest
8.77
Current Liabilities
5.39
Payables And Accrued Expenses
2.21
Payables
0.92
Accounts Payable
0.92
Current Accrued Expenses
1.28
Pensionand Other Post Retirement Benefit Plans Current
1.67
Current Debt And Capital Lease Obligation
1.51
Current Capital Lease Obligation
1.51
Total Non Current Liabilities Net Minority Interest
3.38
Long Term Debt And Capital Lease Obligation
3.38
Long Term Capital Lease Obligation
3.38
Non Current Deferred Liabilities
—
Stockholders Equity
24.94
Common Stock Equity
24.94
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
1.44
Ordinary Shares Number
1.44
Treasury Shares Number
0.00
Additional Paid In Capital
116.15
Retained Earnings
-91.22
Total Equity Gross Minority Interest
24.94
Total Capitalization
24.94
Working Capital
19.23
Invested Capital
24.94
Total Debt
4.89
Capital Lease Obligations
4.89
Net Tangible Assets
24.94
Tangible Book Value
24.94
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-12.71
+47.36%
-24.15
-3.47%
-23.34
+3.24%
-24.12
Cash Flow From Continuing Operating Activities
-12.71
+47.36%
-24.15
-3.47%
-23.34
+3.24%
-24.12
Net Income From Continuing Operations
-19.44
+36.13%
-30.44
-1.43%
-30.01
-5.21%
-28.52
Depreciation Amortization Depletion
2.50
-5.80%
2.65
+6.16%
2.50
+126.75%
1.10
Depreciation
2.50
-5.80%
2.65
+6.16%
2.50
+126.75%
1.10
Depreciation And Amortization
2.50
-5.80%
2.65
+6.16%
2.50
+126.75%
1.10
Stock Based Compensation
3.19
-36.22%
5.00
+14.42%
4.37
+26.05%
3.47
Operating Gains Losses
—
0.04
—
—
Gain Loss On Sale Of PPE
0.00
-100.00%
0.04
0.00
—
Change In Working Capital
1.04
+173.51%
-1.41
-592.16%
-0.20
-20.00%
-0.17
Change In Prepaid Assets
0.67
-64.53%
1.89
+174.17%
0.69
+132.92%
-2.09
Change In Payables And Accrued Expense
0.51
+120.71%
-2.44
-1220.54%
-0.18
-107.60%
2.43
Change In Accrued Expense
0.59
+130.71%
-1.91
-339.70%
0.80
-13.85%
0.92
Change In Payable
-0.08
+85.05%
-0.54
+45.46%
-0.98
-164.97%
1.51
Change In Account Payable
-0.08
+85.05%
-0.54
+45.46%
-0.98
-164.97%
1.51
Change In Other Current Assets
0.13
+745.00%
-0.02
0.00
+100.00%
-0.10
Change In Other Current Liabilities
-0.27
+68.14%
-0.84
-18.36%
-0.71
-71.01%
-0.41
Investing Cash Flow
0.00
+100.00%
-0.19
+68.83%
-0.60
+83.81%
-3.71
Cash Flow From Continuing Investing Activities
0.00
+100.00%
-0.19
+68.83%
-0.60
+83.81%
-3.71
Net PPE Purchase And Sale
0.00
+100.00%
-0.19
+68.83%
-0.60
+83.81%
-3.71
Purchase Of PPE
0.00
+100.00%
-0.19
+68.83%
-0.60
+83.81%
-3.71
Capital Expenditure
—
-0.19
+68.83%
-0.60
+83.81%
-3.71
Financing Cash Flow
28.64
+101.90%
14.18
-47.55%
27.04
+200.89%
8.99
Cash Flow From Continuing Financing Activities
28.64
+101.90%
14.18
-47.55%
27.04
+200.89%
8.99
Net Issuance Payments Of Debt
-0.69
+12.72%
-0.79
+0.50%
-0.80
-29.76%
-0.61
Issuance Of Debt
—
—
—
—
Repayment Of Debt
-0.69
+12.72%
-0.79
+0.50%
-0.80
-29.76%
-0.61
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
-0.69
+12.72%
-0.79
+0.50%
-0.80
-29.76%
-0.61
Net Long Term Debt Issuance
-0.69
+12.72%
-0.79
+0.50%
-0.80
-29.76%
-0.61
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
27.07
+172.22%
9.94
-59.52%
24.56
+157.43%
9.54
Proceeds From Stock Option Exercised
2.26
-55.82%
5.12
+56.31%
3.28
+5273.77%
0.06
Net Other Financing Charges
—
-0.09
—
—
Changes In Cash
15.93
+256.88%
-10.15
-427.06%
3.10
+116.26%
-19.09
Beginning Cash Position
11.39
-47.14%
21.54
+16.84%
18.43
-50.54%
37.27
End Cash Position
27.09
+143.63%
11.12
-47.75%
21.28
+17.05%
18.18
Free Cash Flow
-12.71
+47.76%
-24.34
-1.65%
-23.94
+13.97%
-27.83
Common Stock Issuance
27.07
+172.22%
9.94
-59.52%
24.56
+157.43%
9.54
Issuance Of Capital Stock
27.07
+172.22%
9.94
-59.52%
24.56
+157.43%
9.54
Net Preferred Stock Issuance
—
—
—
—
Other Cash Adjustment Outside Changein Cash
-0.22
+17.29%
-0.27
-3.91%
-0.26
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category